The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We encourage all meeting attendees to take advantage of the opportunities presented at the meeting to learn about the latest breakthroughs in cancer immunology, attend sessions outside your own areas of expertise and network with other scientists and clinicians interested in cancer immunology and immunotherapy.
The AACR Annual Meeting 2013 was held in Washington, D.C., from April 6-10.
The Cancer Immunology Working Group (CIMM) hosted a variety of sessions and events at the Annual Meeting, including:
Cancer Immunology Working Group Town Meeting: Joining Efforts in Cancer Immunotherapy, co-sponsored by CIMM and the Association for Cancer Immunotherapy (CIMT) Immunoguiding Program (CIP)
Sunday, April 7, 2013
6:00 - 9:00 p.m.
Renaissance Hotel, Grand Ballroom North
Chairpersons:
Elizabeth M. Jaffee, M.D., Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD
Robert Vonderheide, M.D., DPhil., Abramson Family Research Cancer Institute of the University of Pennsylvania, Philadelphia, PA
This co-sponsored session was attended by more than 268 individuals who had an opportunity to hear from our colleagues in the AACR-Cancer Immunology (CIMM) Working Group and the Association for Cancer Immunotherapy Immunoguiding Program speak on "Joining Efforts in Cancer Immunotherapy." After this exciting program, the new AACR journal Cancer Immunology Research was launched and a reception followed. Attendees learned about these and other important CIMM initiatives, met members of the working group and steering committee, in addition to taking advantage of the opportunity to join the CIMM Working Group.
Speakers included:
Philipp Beckhove, Translational Immunology Division at the German Cancer Research Center
To be announced
A. Karolina Palucka, Baylor Institute for Immunology Research
Exploiting Innate Receptors on Tumor Infiltrating DCs for Breast Cancer Rejection
Sebastian Kreiter, Translational Oncology Unit (TRON) at the University Medical Center-Mainz
Exploiting the Mutanome for Tumor Vaccination – Insights from Preclinical Work
Joint Cancer Immunology/Tumor Microenvironment (TME) Working Group
Evening Scientific Session: Innate Responses and the Tumor Microenvironment
Monday, April 8, 2013
6:00-8:00 p.m.
Grand Hyatt, Bridge Rooms
This jointly-sponsored Working Group Session was attended by 248+ individuals, comprised of CIMM Members and other interested Annual Meeting registrants.
Chairpersons:
Elizabeth M. Jaffee, M.D, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD
M. Celeste Simon, Ph.D., Abramson Family Research Cancer Institute of the University of Pennsylvania, Philadelphia, PA
It is now clear that the tumor microenvironment includes multiple innate and adaptive components of the immune system that, together with tumor and tissue components, regulate tumor formation, progression and metastasis. The chairpersons of the Cancer Immunology and Tumor Microenvironment Working Groups prepared this evening scientific session to hear leaders from both fields present their most current view of these important interactions.
Speakers included:
Dafna Bar-Sagi, New York University Langone Medical Center, New York, NY
To be announced
John S. Condeelis Sr., Albert Einstein College of Medicine, Bronx, NY
Tumor Microenvironments Supporting Interactions between Tumor Cells and Macrophases in Breast Tumors
M. Celeste Simon, Ph.D., Abramson Family Research Cancer Institute of the University of Pennsylvania, Philadelphia, PA
HIFs, Hypoxia and Tumor Progression
Other CIMM-Related Content
Current Concepts in Diagnostics and Therapeutics
Using Genomics to Guide Cancer Immunotherapy
Tuesday, April 9, 2013, 1:00 p.m. - 3:00 p.m.; Room 152
Educational Sessions and Methods Workshops
Tumor Immunology and Immunotherapy for Non-Immunologists
Saturday, April 6, 2013, 8:00 a.m. - 10:00 a.m.; Room 202
Cancer Immunology for the Non-Immunologist - Tutorial
Saturday, April 6, 2013, 10:00 a.m. - 12:00 noon; Room 206
Immune Modulation in the Tumor Microenvironment: Tregs and Other Factors Regulating Host Response
Saturday, April 6, 2013, 10:15 a.m. - 12:15 p.m.; Room 145
Measuring and Understanding Immune Responses to Cancer Immunotherapy
Saturday, April 6, 2013, 1:00 p.m. - 3:00 p.m.; Room 151
Genetically Engineered Immune Cells in Immunotherapy
Saturday, April 6, 2013, 3:15 p.m. - 5:15 p.m.; Room 145
Major Symposia
Innate Immune Sensing in the Tumor Microenvironment
Tuesday, April 9, 2013, 10:30 a.m. - 12:30 p.m.; Room 145
New Cancer Vaccines
Tuesday, April 9, 2013, 10:30 a.m. - 12:30 p.m.; Room 202
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies
Wednesday, April 10, 2013; 11:00 a.m. - 1:00 p.m.; Ballroom C
Inflammation and Cancer
Wednesday, April 10, 2013, 11:00 a.m. - 1:00 p.m.; Room 207
Minisymposia
Back to the Future: Next Generation Vaccination and Cellular Immune Therapies
Tuesday, April 9, 2013, 3:00 p.m. - 5:00 p.m.; Room 151
Plenary Sessions
From Discovery Science to Precision Medicine: Paving the Path to Progress
(Immune checkpoint blockage: Unleashing the immune systems against cancer)
Sunday, April 7, 2013, 9:15 a.m. - 12:00 noon; Hall D
Poster Sessions
Immunosuppression
Sunday, April 7, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 21
Vaccines, Immune Modulatory Agents, and Environment
Sunday, April 7, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 22
Cytokines, Modification of the Tumor Microenvironment and Intervention
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 5
Immunotherapy
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 6
Macrophages as Key Players in the Tumor Microenvironment
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 17
Chemokines, Cytokines and Tumor Microenvironment Interaction
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 13
Tumor-Promoting Inflammation
Tuesday, April 9, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 22
Immune Therapeutics and Monoclonal Antibodies 1
Tuesday, April 9, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 21
Immune Therapies: Adoptive Cellular Therapies and Combinations
Tuesday, April 9, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 22
Drug-Immune Interactions
Wednesday, April 10, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 4
Immune Therapeutics and Monoclonal Antibodies 2
Wednesday, April 10, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 5
Immunity: Cancer-Related Inflammation and Microenvironmental Crosstalk
Wednesday, April 10, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 16
Chemotherapy and Immune Therapy Targeting the Tumor Microenvironment
Wednesday, April 10, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 15